Posted by Michael Wonder on 10 Jul 2017
New lung cancer drug approved for routine use in Scotland
10 July 2017 - A drug which could help advanced lung cancer sufferers has been approved for use on the NHS in Scotland.
Experts believe around 150 patients with a rare form of the cancer could benefit from pembrolizumab every year.
It is one of three medicines given the green light for routine use by the Scottish Medicines Consortium.
